O’ Nuallain S, Flanagan O, Raffat I, Avalos G, Dineen B. The prevalence of Down syndrome in County Galway. Ir Med. 2009;100:329–31.
Google Scholar
Carothers AD, Hecht CA, Hook EB. International variation in reported live birth prevalence rates of Down syndrome, adjusted for maternal age. J Med Genet. 1999;36:386–93.
Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States. Birth Defects Res A Clin Mol Teratol. 2006;76:747–56.
Murthy SK, Malhotra AK, Mani S, Shara ME, Al Rowaished EE, Naveed S, et al. Incidence of Down syndrome in Dubai. Med Princ Pract. 2007;16:25–8.
Article
PubMed
Google Scholar
Wahab AA, Bener A, Teebi AS. The incidence patterns of Down syndrome in Qatar. Clin Genet. 2006;69:360–2.
Article
PubMed
Google Scholar
Mégarbané A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethoré MO et al. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med. 2009;11:611–6.
Article
PubMed
Google Scholar
Gardiner KJ. Molecular basis of pharmacotherapies for cognition in Down syndrome. Trends Pharmacol Sci. 2010;31:66–73.
Article
CAS
PubMed Central
PubMed
Google Scholar
Prandini P, Deutsch S, Lyle R, Gagnebin M, Delucinge Vivier C, Delorenzi M et al. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet. 2007;81:252–63.
Article
CAS
PubMed Central
PubMed
Google Scholar
Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn. 1999;19:142–5.
Article
CAS
PubMed
Google Scholar
Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH, et al. The changing survival profile of people with Down’s syndrome: implications for genetic counselling. Clin Genet. 2002;62:390–3.
Article
CAS
PubMed
Google Scholar
Lyle R, Bena F, Gagos S, Gehrig C, Lopez G, Schinzel A, et al. Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet. 2009;17:454–66.
Article
CAS
PubMed Central
PubMed
Google Scholar
Ermak G, Harris CD, Battocchio D, Davies KJ. RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3beta. FEBS J. 2006;273:2100–9.
Article
CAS
PubMed
Google Scholar
Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet. 2004;5:725–38.
Article
CAS
PubMed
Google Scholar
Sinet PM, Theopile D, Rahmani Z, Chettouch Z, Blovin JL, Prier M, et al. Mapping of Down syndrome phenotype on chromosome 21 at the molecular level. Biomed Pharmacother. 1994;48(5–6):247–52.
Article
CAS
PubMed
Google Scholar
Epstein CJ, Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic & Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001. p. 1223–56.
Google Scholar
Pritchard MA, Kola I. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome. J Neural Transm Suppl. 1999;57:293–303.
CAS
PubMed
Google Scholar
Patterson D. Genetic mechanisms involved in the phenotype of Down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13:199–206.
Article
PubMed
Google Scholar
Shapiro BL. Down syndrome–a disruption of homeostasis. Am J Med Genet. 1983;14:241–69.
Article
CAS
PubMed
Google Scholar
Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet. 1993;1:114–24.
CAS
PubMed
Google Scholar
Ohira M, Ichikawa H, Suzuki E, Iwaki M, Suzuki K, Saito-Ohara F, et al. A 1.6-Mb P1-based physical map of the Down syndrome region on chromosome 21. Genomics. 1996;33:65–74.
Article
CAS
PubMed
Google Scholar
Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci U S A. 2009;106:12031–6.
Article
CAS
PubMed Central
PubMed
Google Scholar
Niebuhr E. Down's syndrome. The possibility of a pathogenetic segment on chromosome no. 21. Humangenetik. 1974;21:99–101.
CAS
PubMed
Google Scholar
Holland AJ, Hon J, Huppert FA, Stevens F. Incidence and course of dementia in people with Down’s syndrome: findings from a population-based study. J Intellect Disabil Res. 2000;44:138–46.
Article
PubMed
Google Scholar
Holland AJ, Hon J, Huppert FA, Stevens F, Watson P. Population-based study of the prevalence and presentation of dementia in adults with Down’s syndrome. Br J Psychiatry. 1998;172:493–8.
Article
CAS
PubMed
Google Scholar
Janicki MP, Dalton AJ. Prevalence of dementia and impact on intellectual disability services. Ment Retard. 2000;38:276–88.
Article
CAS
PubMed
Google Scholar
Johannsen P, Christensen JE, Mai J. The prevalence of dementia in Down syndrome. Dementia. 1996;7:221–5.
CAS
PubMed
Google Scholar
Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46:849–53.
Article
CAS
PubMed
Google Scholar
EL Jones, CG Ballard, VP Prasher, M Arno, S Tyrer, B Moore et al. An Intron 7 polymorphism in APP affects the age of Dimentia in Down Syndrome. Int J Alzheimers Dis. 2011;5. doi:10.4061/2011/929102
Salehi A, Delcroix JD, Belichenko PV, Zhan KWC, Valletta JS, Takimoto-Kimura, et al. Increased App expression in a mouse model of Down’s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006;51:29–42.23.
Article
CAS
PubMed
Google Scholar
Myllykangas L, Wavrant –De Vrieze F, Polvikoski T, Notkola IL, Sulkava R, Niinisto L. Chromosome 21 BACE2 haplotype associates with Alzheimer's disease: a two-stage study. J Neurol Sci. 2005;236(1–2):17–24.
Article
CAS
PubMed
Google Scholar
Jones EL, Mok K, Hanney M, Harold D, Sims R, Williams J. Evidence that PICALM affects age at onset of Alzheimer’s dementia in Down syndrome. Neurobiol Aging. 2013;34(10):244.
Article
Google Scholar
Urbano R. Health issues among person with down syndrome. 2012.
Maslen CL, Babcock D, Robinson SW, Bean LJ, Dooley KJ, Willour VL, et al. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet. 2006;140:2501–5.
Craig B. Atrioventricular septal defect: from fetus to adult. Heart. 2006;92(12):1879–85.
Article
PubMed Central
PubMed
Google Scholar
Rup PA, Fouad GT, Egelston CA, Reifsteck CA, Oslon SB, Knosp WM, et al. Identification, genomic organization and mRNA expression of CRELD1, the founding member of a unique family of matricellular proteins. Gene. 2002;293:47–57.
Article
Google Scholar
Sheffield VC, Pierpont ME, Nishimura D, Beek JS, Burns TL, Berg MA, et al. Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Hum Mol Genet. 1997;6:117–21.
Article
CAS
PubMed
Google Scholar
Priestley MD, Water J, Maliszewska C, Latif F, Maher ER. Detailed mapping of a congenital heart disease gene in chromosome 3p25. J Med Genet. 2000;37:581–7.
Article
PubMed Central
PubMed
Google Scholar
Robinsom SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, Maslen CL, et al. Missense mutation in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet. 2003;72:1047–52.
Article
Google Scholar
Brewster HF, Cannon HE. Acute lymphatic leukemia: Report of a case in eleventh month mongolina idiot. New Orleans Med Surg J. 1930;82:872–3.
Google Scholar
Krivit W, Good RA. Simultaneous occurrence of mongolism and leukemia; report of a nationwide survey. AMA J Dis Child. 1957;94:289–93.
Article
CAS
PubMed
Google Scholar
Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down’s syndrome. Lancet. 2000;355:165–9.
Article
CAS
PubMed
Google Scholar
Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32(1):148–52.
Article
CAS
PubMed
Google Scholar
Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16(13):3965–73.
Article
CAS
PubMed Central
PubMed
Google Scholar
Kearney L, Gonzalez De Castro D, Yeung J, Procter J, Horsley SW, Eguchi-Ishimae M, et al. Specific JAK2 mutation (JAK2R683) andmultiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood. 2009;113(3):646–8.
Article
CAS
PubMed
Google Scholar
Morrison RA, McGrath A, Davidson G, Brown JJ, Murray GD, Lever AF. Low blood pressure in Down’s syndrome, a link with Alzheimer’s disease? Hypertension. 1996;28:569–75.
Article
CAS
PubMed
Google Scholar
Draheim CC, McCubbin JA, Williams DP. Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome. Am J Ment Retard. 2002;107:201–11.
Article
PubMed
Google Scholar
Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3’ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet. 2007;81:405–13.
Article
CAS
PubMed Central
PubMed
Google Scholar
Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet. 1998;77:431–8.
Article
CAS
PubMed
Google Scholar
Berrocal T, Lamas M, Gutiérrez J. Congenital Anomalies of the Small Intestine, Colon, and Rectum. Radiographics Radiol Bras. 1999;19:1219–36.
Article
CAS
Google Scholar
Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45:1–14.
Article
CAS
PubMed
Google Scholar
Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27(1):1–7.
Article
PubMed
Google Scholar
Reena MS, Pisani PO Conversano F, Perrone E, Casciaro E, Renzo GCD et al. Sonographic markers for early diagnosis of fetal malformations. World J Radiol. 2013;10:356-371.
Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstetrics Gynecol. 2013;41(3):247–61.
Article
CAS
Google Scholar
F.D. Malone, M.E D'Alton. First trimester sonographic screenign for Down syndrome. Obstetrics and Gynecology. 2003;102:1066-79.
Kuo WL. Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet. 1991;49:112–9.
CAS
PubMed Central
PubMed
Google Scholar
Shalu J, Sarita A, Inusha P, Parag T, Shubha P. Diagnosis of Down Syndrome and Detection of Origin of Nondisjunction by Short Tandem Repeat Analysis. Genetic Test Mol Biomark. 2010;14:4.
Google Scholar
Shalu J, Inusha P, Shubha RP, Sarita A. Multiplex quantitative fluorescent polymerase chain reaction for detection of aneuploidies. Genet Test Mol Biomarker. 2012;16:624–7.
Article
Google Scholar
Armour JA, Sismani C, Patsalis PC, Cross G. Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res. 2000;28:605–9.
Article
CAS
PubMed Central
PubMed
Google Scholar
Slater HR, Bruno DL, Ren H, Pertile M, Schouten JP, Choo KH. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J Med Genet. 2003;40:907–12.
Article
CAS
PubMed Central
PubMed
Google Scholar
Van Veghel-Plandsoen M, Wouters C, Kromosoeto J. Multiplex ligation-dependent probe amplification is not suitable for detection of low-grade mosaicism. Eur J Hum Genet. 2011;19:1009–12.
Article
PubMed Central
PubMed
Google Scholar
S Deutsch, U Choudhury, SE Antonarakis. Detection of trisomy 21 and other aneuploidies by paralogous gene quantification. J Med Genet (in the press).
Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP. A tiling resolution DNA microarray with complete coverage of the human genome. Nature Genet. 2004;36:299–303.
Article
CAS
PubMed
Google Scholar
Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J et al. Assembly of microarrays for genome- wide measurement of DNA copy number. Nature Genet. 2001;29:263–4.
Article
CAS
PubMed
Google Scholar
Walknowska J, Conte FA, Grumbach MM. Practical and theoretical implications of fetal- maternal lymphocyte transfer. Lancet. 1969;1:1119–22.
Article
CAS
PubMed
Google Scholar
Daniels G, Finning K, Martin P, Massey E. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn. 2009;29:101–7.
Article
CAS
PubMed
Google Scholar
Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–7.
Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med. 2002;346:1502.
Article
PubMed
Google Scholar
Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update. 2009;15:139–51.
Article
CAS
PubMed
Google Scholar
Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27:415–8.
Chim SS, Jin S, Lee TY, Lun FM, Lee WS, Chan LY, et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem. 2008;54:500–11.
Article
CAS
PubMed
Google Scholar
Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet. 2008;24:133–41.
Article
CAS
PubMed
Google Scholar
Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clin Chem. 2009;55:641–58.
Article
CAS
PubMed
Google Scholar
Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008;105:16266–71.
Article
CAS
PubMed Central
PubMed
Google Scholar
Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A. 2008;105:20458–63.
Article
CAS
PubMed Central
PubMed
Google Scholar
Chiu RWK, Sun H, Akolekar R, Clouser C, Lee C, McKernan K, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem. 2010;56:459–63.
Article
CAS
PubMed
Google Scholar